Cargando…
Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs
[Image: see text] A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears ex...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512009/ https://www.ncbi.nlm.nih.gov/pubmed/36066412 http://dx.doi.org/10.1021/acs.jmedchem.2c00946 |
_version_ | 1784797762485747712 |
---|---|
author | Obi, Peter Natesan, Senthil |
author_facet | Obi, Peter Natesan, Senthil |
author_sort | Obi, Peter |
collection | PubMed |
description | [Image: see text] A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. The experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand access and binding is often overlooked and poorly understood. Using classical and enhanced molecular dynamics simulations, we show that membrane lipids are critical in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor. The observed differences in the binding affinity and cooperativity arise from the functional groups that interact primarily with lipids. Our results demonstrate the significance of incorporating membrane lipids as an integral component of transmembrane sites for accurate characterization, binding-affinity calculations, and lead optimization in drug discovery. |
format | Online Article Text |
id | pubmed-9512009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-95120092023-09-06 Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs Obi, Peter Natesan, Senthil J Med Chem [Image: see text] A growing number of G-protein-coupled receptor (GPCR) structures reveal novel transmembrane lipid-exposed allosteric sites. Ligands must first partition into the surrounding membrane and take lipid paths to these sites. Remarkably, a significant part of the bound ligands appears exposed to the membrane lipids. The experimental structures do not usually account for the surrounding lipids, and their apparent contribution to ligand access and binding is often overlooked and poorly understood. Using classical and enhanced molecular dynamics simulations, we show that membrane lipids are critical in the access and binding of ORG27569 and its analogs at the transmembrane site of cannabinoid CB1 receptor. The observed differences in the binding affinity and cooperativity arise from the functional groups that interact primarily with lipids. Our results demonstrate the significance of incorporating membrane lipids as an integral component of transmembrane sites for accurate characterization, binding-affinity calculations, and lead optimization in drug discovery. American Chemical Society 2022-09-06 2022-09-22 /pmc/articles/PMC9512009/ /pubmed/36066412 http://dx.doi.org/10.1021/acs.jmedchem.2c00946 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Obi, Peter Natesan, Senthil Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs |
title | Membrane Lipids
Are an Integral Part of Transmembrane
Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor
Bound to a Negative Allosteric Modulator, ORG27569, and Analogs |
title_full | Membrane Lipids
Are an Integral Part of Transmembrane
Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor
Bound to a Negative Allosteric Modulator, ORG27569, and Analogs |
title_fullStr | Membrane Lipids
Are an Integral Part of Transmembrane
Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor
Bound to a Negative Allosteric Modulator, ORG27569, and Analogs |
title_full_unstemmed | Membrane Lipids
Are an Integral Part of Transmembrane
Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor
Bound to a Negative Allosteric Modulator, ORG27569, and Analogs |
title_short | Membrane Lipids
Are an Integral Part of Transmembrane
Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor
Bound to a Negative Allosteric Modulator, ORG27569, and Analogs |
title_sort | membrane lipids
are an integral part of transmembrane
allosteric sites in gpcrs: a case study of cannabinoid cb1 receptor
bound to a negative allosteric modulator, org27569, and analogs |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512009/ https://www.ncbi.nlm.nih.gov/pubmed/36066412 http://dx.doi.org/10.1021/acs.jmedchem.2c00946 |
work_keys_str_mv | AT obipeter membranelipidsareanintegralpartoftransmembraneallostericsitesingpcrsacasestudyofcannabinoidcb1receptorboundtoanegativeallostericmodulatororg27569andanalogs AT natesansenthil membranelipidsareanintegralpartoftransmembraneallostericsitesingpcrsacasestudyofcannabinoidcb1receptorboundtoanegativeallostericmodulatororg27569andanalogs |